Vaxcyte Inc (PCVX) — Long-term Investment Intensity
Vaxcyte Inc (PCVX) has a Long-term Investment Intensity of 32.5% as of June 2026. Long-term investments of $1.02 Billion represent 32.5% of total assets of $3.14 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Vaxcyte Inc asset resilience ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Vaxcyte Inc Long-term Investment Intensity (2021–2025)
This chart shows how Vaxcyte Inc's Long-term Investment Intensity has evolved across 5 annual periods from 2021 to 2025. As of June 2026, the intensity stands at 32.5%, reflecting long-term investments of $1.02 Billion against total assets of $3.14 Billion USD. For the complete balance sheet picture, see PCVX asset base.
Annual Long-term Investment Intensity for Vaxcyte Inc (2021–2025)
The table below presents the year-by-year Long-term Investment Intensity for Vaxcyte Inc from 2021 to 2025, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read PCVX total liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 28.9% | $881.66 Million | $3.05 Billion | ▼ -10.6 pp |
| 2024 | 39.5% | $1.39 Billion | $3.51 Billion | ▲ +28.0 pp |
| 2023 | 11.6% | $162.68 Million | $1.41 Billion | ▲ +8.9 pp |
| 2022 | 2.6% | $26.55 Million | $1.01 Billion | ▼ -5.7 pp |
| 2021 | 8.4% | $27.12 Million | $324.34 Million | — |